Volume 13, Issue 1, Pages 233-240 (January 2016) Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study Faisal Rahman, BM BCh, Na Wang, MA, Xiaoyan Yin, PhD, Patrick T. Ellinor, MD, PhD, Steven A. Lubitz, MD, MPH, Paul A. LeLorier, MD, FACC, David D. McManus, MD, ScM, Lisa M. Sullivan, PhD, Sudha Seshadri, MD, Ramachandran S. Vasan, MD, Emelia J. Benjamin, MD, ScM, Jared W. Magnani, MD, MSc Heart Rhythm Volume 13, Issue 1, Pages 233-240 (January 2016) DOI: 10.1016/j.hrthm.2015.07.031 Copyright © 2016 Heart Rhythm Society Terms and Conditions
Figure 1 Ten-year cumulative incidence of atrial fibrillation in the atrial flutter and referent groups. Graph adjusted for competing risk of death. Heart Rhythm 2016 13, 233-240DOI: (10.1016/j.hrthm.2015.07.031) Copyright © 2016 Heart Rhythm Society Terms and Conditions
Figure 2 Ten-year cumulative incidence of myocardial infarction (A), heart failure (B) , stroke (C) , and all-cause mortality (D) in Framingham Heart Study participants with atrial flutter, atrial fibrillation (AF), and referents. Graphs adjusted for competing risk of death (except for all-cause mortality). Heart Rhythm 2016 13, 233-240DOI: (10.1016/j.hrthm.2015.07.031) Copyright © 2016 Heart Rhythm Society Terms and Conditions